Sarepta Therapeutics (SRPT) shares surged 8.7% due to strong earnings and revenue growth.

From Nasdaq: 2025-03-20 01:58:00

Sarepta Therapeutics (SRPT) shares surged 8.7% to $79.97, rebounding from a recent drop due to reports of a patient’s death following gene therapy treatment. Earnings are expected to be $2.25 per share, up 208.2% year-over-year, with revenues of $692.54 million, a 67.5% increase. Keep an eye on SRPT for potential future strength.

In the same industry, MiMedx (MDXG) saw a 2.2% increase to $8.09 with an EPS estimate of $0.06, up 20% in the past month. Global semiconductor manufacturing is projected to grow from $452 billion in 2021 to $803 billion by 2028. Consider investing in top chip stocks for potential growth opportunities.



Read more at Nasdaq: Strength Seen in Sarepta Therapeutics (SRPT): Can Its 8.7% Jump Turn into More Strength?